Alvotech (ALVO) Interest Income - Total (2021 - 2026)
Alvotech's (ALVO) quarterly Interest Income - Total came in at $16.4 million in Q2 2026, up 171.54% on a YoY basis from $6.0 million in Q2 2025, and up 149.11% quarter-over-quarter from -$33.4 million in Q1 2026.
Analysis
Alvotech (ALVO) Interest Income - Total (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Interest Income - Total for 6 consecutive years, with $16.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest Income - Total rose 171.54% year-over-year to $16.4 million; the trailing twelve-month figure through Jun 2026 stood at -$66.2 million (up 70.9% YoY), and the FY2025 full-year result was -$198.5 million, down 147.67% from the prior year.
- Interest Income - Total climbed to $16.4 million in Q2 2026 per ALVO's latest filing, from -$33.4 million in the prior quarter.
- Across five years, Interest Income - Total topped out at $16.4 million in Q2 2026 and bottomed at -$126.3 million in Q1 2025.
- Historically, Interest Income - Total has averaged -$39.6 million across 5 years, with a median of -$25.4 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Interest Income - Total slumped 16031.29% in 2025, then jumped 171.54% in 2026.
- Over 5 years, Interest Income - Total stood at -$2.5 million in 2022, then tumbled by 89.21% to -$4.8 million in 2023, then slumped by 1561.73% to -$80.1 million in 2024, then soared by 65.31% to -$27.8 million in 2025, then surged by 159.02% to $16.4 million in 2026.
- According to Business Quant data, Interest Income - Total over the past three periods registered $16.4 million, -$33.4 million, and -$27.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Total (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.91 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.15 Bn | 18.27 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.68 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 526.37 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | 16.41 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 408.32 Mn | 367.07 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 182.68 Mn | 182.68 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.41 Mn |
| Jun 30, 2026 | 16.41 Mn |
| Mar 31, 2026 | -33.41 Mn |
| Mar 31, 2026 | -33.41 Mn |
| Dec 31, 2025 | -27.81 Mn |
| Dec 31, 2025 | -27.81 Mn |
| Sep 30, 2025 | -21.44 Mn |
| Sep 30, 2025 | -21.44 Mn |
| Jun 30, 2025 | -22.94 Mn |
| Jun 30, 2025 | -22.94 Mn |
| Mar 31, 2025 | -126.31 Mn |
| Mar 31, 2025 | -126.31 Mn |
| Dec 31, 2024 | -80.15 Mn |
| Dec 31, 2024 | -80.15 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | -80.04 Mn |
| Jun 30, 2024 | -80.04 Mn |
| Mar 31, 2024 | -783,000.00 |
| Mar 31, 2024 | -783,000.00 |